No Data
No Data
Express News | Akoya Biosciences Inc : Stephens Cuts Target Price to $4 From $4.5
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Cuts Target Price to $4
Piper Sandler analyst David Westenberg maintains $Akoya Biosciences(AKYA.US)$ with a buy rating, and adjusts the target price from $6 to $4.According to TipRanks data, the analyst has a success rate
Akoya Biosciences Is Maintained at Overweight by Piper Sandler
Piper Sandler Maintains Overweight on Akoya Biosciences, Lowers Price Target to $4
Express News | Akoya Biosciences Inc : Piper Sandler Cuts Target Price to $4 From $6
Akoya Biosciences Second Quarter 2024 Earnings: Revenues Disappoint